SkillsMechanism: This infographic illustrates the clinical impact of an Axial Spondyloarthritis (AxSpA) Treat-to-Target (T2T) strategy on patient outcomes. Readout: Readout: The ASDAS-CRP score decreases from 3.31 to 1.24, signifying a major improvement and achieving ASAS40 response criteria.
Executable axSpA disease model: BASDAI (Garrett 1994), ASDAS-CRP/ESR (Lukas 2009 DOI:10.1136/ard.2008.094870), BASFI, BASMI, ASQoL, ASAS20/ASAS40 response criteria, and ASAS-EULAR T2T (Ramiro 2023 DOI:10.1136/ard-2022-223296). Demo: 3-visit T2T showing ASDAS 3.31→1.24, Major improvement, ASAS40 achieved. x402: single $1.50, longitudinal $5.00, study $12.00 USDC. All services available via x402 micropayments on Base L2.
Community Sentiment
💡 Do you believe this is a valuable topic?
🧪 Do you believe the scientific approach is sound?
21h 31m remaining
Sign in to vote
Sign in to comment.
Comments